1995年8月以来,我院应用美国SciClone公司提供的胸腺肽a—1(Tal)及干扰素a—2b(IFNa—2b)联合治疗深圳地区的慢性乙型病毒性肝炎(CH—B)30例及慢性丙型病毒性肝炎(CH—C)10例.本文旨在验证及评估Tal加IFNa—2b联合治疗慢性乙型、丙型病毒性肝炎的临床效果及安全性.l 资料与方法1.1 对象:所选病例均为在本院住院的患者,临床及病原学诊断,均符合1995年北京全国第五届传染 Since August 1995, 30 cases of chronic hepatitis B (CH-B) in Shenzhen have been treated in our hospital with thymosin alpha-1 (Tal) and interferon alpha-2b (IFNa-2b) And chronic hepatitis C (CH-C) 10 cases.This paper aims to verify and evaluate the combination of Tal plus IFNa-2b treatment of chronic hepatitis B and C, the clinical efficacy and safety.l Materials and Methods 1.1 Object : Selected cases are hospitalized patients in our hospital, clinical and etiological diagnosis, are in line with the 1995 Beijing Fifth National Infection